论文部分内容阅读
本文探讨了0.25％硝普钠气雾剂对13名慢性支气管炎忠者雾化吸入后5,15,30,60.分钟的支气管扩张作用。结果表明,硝普钠吸入后各肺功能均值与安慰剂相比均具有非常显著差异(P<0.01)。肺功能参数前后增加的百分比,FEV_(1.0)FVC、MEF、(50)、&_(25)分别平均增加9.8％、10.7％、24.9％、24.0％、&46.7％,从而提示硝普钠对于慢性支气管炎患者具有明显的支气管扩张作用,为硝普钠的一药多用老药新用开拓了新的途径。
This article explored the bronchodilatory effects of 0.25% sodium nitroprusside aerosol at 5, 15, 30, 60 minutes after aerosol inhalation of 13 chronic bronchitis patients. The results showed that after inhaled sodium nitroprusside average lung function compared with placebo have very significant differences (P <0.01). The mean percentage of FEV_ (1.0) FVC, MEF, (50), and _ (25) increased by 9.8%, 10.7%, 24.9%, 24.0%, and 46.7% on average respectively, Chronic bronchitis patients with significant bronchiectasis, a drug for sodium nitropruss with a new multi-use medicine to open up new avenues.